Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
Status:
Active, not recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized placebo controlled trial to evaluate whether antenatal corticosteroids
can decrease the rate of neonatal respiratory support, thus decreasing the rate of NICU
admissions and improving short-term outcomes in the late preterm infant. The use of antenatal
corticosteroids has been shown to be beneficial in women at risk for preterm delivery prior
to 34 weeks but has not been evaluated in those likely to deliver in the late preterm period
Phase:
Phase 3
Details
Lead Sponsor:
The George Washington University Biostatistics Center
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Heart, Lung, and Blood Institute (NHLBI)